CClinicalTrials.gg
CompletedNCT07460388Pilates_WBVUpdated Mar 10, 2026

Pilates Plus Whole-Body Vibration in Postmenopausal Women

An interventional study of Pilates plus whole-body vibration in Postmenopausal Women, sponsored by Universidade Estadual do Norte do Parana. Completed. Open to female participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Universidade Estadual do Norte do Parana · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 years 1 month after the study started (first participant enrolled Jan 2017, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
50 Years and older
Sex
Female
01

Study summary

This controlled, quasi-experimental clinical trial investigated the effects of a combined Pilates and whole-body vibration (WBV) intervention on bone mineral density (BMD), muscle strength, postural balance, and quality of life in postmenopausal women. Fifteen women aged 50-71 years initially served as a historical control group in a previous study. After completion of that protocol, ten of these participants underwent a 26-week combined intervention consisting of supervised Pilates exercises and WBV performed three times per week.

BMD was assessed using dual-energy X-ray absorptiometry (DXA). Peak torque of the lower limbs was measured by isokinetic dynamometry. Postural balance was evaluated using a force platform, and quality of life was assessed using the Short Form-36 (SF-36) questionnaire. Outcomes obtained after the combined intervention were compared with those from the historical control phase.

02

Conditions studied

  • Postmenopausal Women
03

In context

Lead sponsor

Universidade Estadual do Norte do Parana is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

(a) no engagement in structured physical exercise for at least six months prior to enrollment; (b) agreement to refrain from participating in any additional physical exercise programs during the study period; (c) ability to perform activities of daily living independently23, 24; (d) presentation of a medical certificate confirming fitness to engage in physical exercise; (e) cognitive status score > 19 on the Mini-Mental State Examination25; and (f) no use of medications aimed at increasing BMD or muscle mass within the previous 12 months.

Exclusion criteria

Exclusion Criteria:

(a) personal decision; (b) adverse events that make participation impossible.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Pilates plus WBV

    Pilates exercises combined with whole-body vibration.

    Other: Pilates plus whole-body vibration

Interventions

  • OtherPilates plus whole-body vibration

    The intervention consisted of a combined protocol integrating supervised mat-based Pilates exercises with whole-body vibration (WBV) performed on a side-alternating vibrating platform. Sessions were conducted three times per week for 26 weeks. Each session included structured Pilates exercises targeting core stability, postural alignment, and lower-limb strengthening, immediately followed by WBV exposure with controlled frequency and amplitude parameters. This combined protocol differs from previous interventions conducted in the same population, in which Pilates and WBV were applied separately. The present study specifically investigated the potential additive or synergistic effects of simultaneously implementing both modalities within the same training session, which had not been previously examined in this cohort.

06

What researchers measure

Primary outcomes

  1. Lumbar spine BMD

    Lumbar spine bone mineral density

    Time frame: From enrollment to the end of treatment, in 6 months

  2. Femoral neck BMD

    Femoral neck bone mineral density

    Time frame: From enrollment to the end of treatment, in 6 months

  3. Total hip BMD

    Total hip bne mineral density

    Time frame: From enrollment to the end of treatment, in 6 months

  4. Trochanter BMD

    Trochanter bone mineral density

    Time frame: From enrollment to the end of treatment, in 6 months

Secondary outcomes

  1. Knee extensor strength at 60º/s

    Peak isokinetic torque of the knee extensor muscles at 60º/s

    Time frame: From enrollment to the end of treatment, in 6 months

  2. Knee flexor strength at 60º/s

    Peak isokinetic torque of knee flexor muscles at 60º/s

    Time frame: From enrollment to the end of treatment, in 6 months

  3. Knee extensor strength 180º/s

    Peak isokinetic torque of knee extensor muscles at 180º/s

    Time frame: From enrollment to the end of treatment, in 6 months

  4. Knee flexor strength 180º/s

    Peak isokinetic torque of knee flexor muscles at 180º/s

    Time frame: From enrollment to the end of treatment, in 6 months

  5. Static balance with bipedal support and eyes open (area - cm2)

    Bipedal support with eyes open (area - cm2)

    Time frame: From enrollment to the end of treatment, in 6 months

  6. Static balance with bipedal support and eyes closed (area - cm2)

    Bipedal support with eyes closed (area - cm2)

    Time frame: From enrollment to the end of treatment, in 6 months

  7. Static balance with semi-tandem support and eyes open (area - cm2)

    Semi-tandem support with eyes open (area - cm2)

    Time frame: From enrollment to the end of treatment, in 6 months

  8. Static balance with semi-tandem support and eyes closed (area - cm2)

    Semi-tandem support with eyes closed (area - cm2)

    Time frame: From enrollment to the end of treatment, in 6 months

  9. Static balance with unipedal support and eyes open (area - cm2)

    Unipedal support with eyes open (area - cm2)

    Time frame: From enrollment to the end of treatment, in 6 months

  10. Static balance with bipedal support and eyes open (anteroposterior displacement - cm/s)

    Bipedal support with eyes open (anteroposterior displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  11. Static balance with bipedal support and eyes closed (anteroposterior displacement - cm/s)

    Bipedal support with eyes closed (anteroposterior displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  12. Static balance with semi-tandem support and eyes open (anteroposterior displacement - cm/s)

    Semi-tandem support with eyes open (anteroposterior displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  13. Static balance with semi-tandem support and eyes closed (anteroposterior displacement - cm/s)

    Semi-tandem support with eyes closed (anteroposterior displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  14. Static balance with unipedal support and eyes open (anteroposterior displacement - cm/s)

    Unipedal support with eyes open (anteroposterior displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  15. Static balance with bipedal support and eyes open (medial-lateral displacement - cm/s)

    Bipedal support with eyes open (medial-lateral displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  16. Static balance with bipedal support and eyes closed (medial-lateral displacement - cm/s)

    Bipedal support with eyes closed (medial-lateral displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  17. Static balance with semi-tandem support and eyes open (medial-lateral displacement - cm/s)

    Semi-tandem support with eyes open (medial-lateral displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  18. Static balance with semi-tandem support and eyes closed (medial-lateral displacement - cm/s)

    Semi-tandem support with eyes closed (medial-lateral displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  19. Static balance with unipedal support and eyes open (medial-lateral displacement - cm/s)

    Unipedal support with eyes open (medial-lateral displacement - cm/s)

    Time frame: From enrollment to the end of treatment, in 6 months

  20. Quality of life (SF-36) - Physical Functioning

    Physical Functioning Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  21. Quality of life (SF-36) - Role-Physical

    Role-Physical Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  22. Quality of life (SF-36) - Bodily Pain

    Bodily Pain Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  23. Quality of life (SF-36) - General Health

    General Health Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  24. Quality of life (SF-36) - Vitality

    Vitality Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  25. Quality of life (SF-36) - Social Functioning

    Social Functioning Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  26. Quality of life (SF-36) - Role-Emotional

    Role-Emotional Domain

    Time frame: From enrollment to the end of treatment, in 6 months

  27. Quality of life (SF-36) - Mental Health

    Mental Health Domain

    Time frame: From enrollment to the end of treatment, in 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — The data will be available in a public repository.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07460388
Lead sponsor
Universidade Estadual do Norte do Parana
Responsible party
Raphael Goncalves de Oliveira (Dr, Universidade Estadual do Norte do Parana) — Principal investigator
First posted
Mar 10, 2026
Start date
Jan 5, 2017
Primary completion
Jul 25, 2017
Completion
Jul 31, 2017
Last update
Mar 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion